17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study. Issue 3 (March 2020) - Shebl, Amgad; Durn, Billie L.; Bril, Vera; Merkies, Ingemar S.J.; Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A.; Sobue, Gen; Lawo, John-Philip; Cornblath, David R.; Mielke, Orell; van Schaik, Ivo N.; et al.